1. Home
  2. CHMI vs INKT Comparison

CHMI vs INKT Comparison

Compare CHMI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.49

Market Cap

83.3M

Sector

Real Estate

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.85

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
INKT
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
51.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
CHMI
INKT
Price
$2.49
$11.85
Analyst Decision
Hold
Buy
Analyst Count
3
2
Target Price
$2.75
$35.00
AVG Volume (30 Days)
290.8K
19.5K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
16.13%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$40,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.73
N/A
P/E Ratio
$132.37
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$4.56
52 Week High
$3.68
$76.00

Technical Indicators

Market Signals
Indicator
CHMI
INKT
Relative Strength Index (RSI) 60.21 44.93
Support Level $2.20 $10.51
Resistance Level $2.52 $12.50
Average True Range (ATR) 0.09 0.87
MACD 0.03 0.12
Stochastic Oscillator 88.57 41.42

Price Performance

Historical Comparison
CHMI
INKT

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: